Overview
Kathryn Asmus is a Hematologist and an Oncologist in Waukesha, Wisconsin. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Lymphocytic Lymphoma (SLL), and Smoldering Multiple Myeloma.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
N16W24131 Riverwood Dr, Waukesha, WI 53188
Childrens Hospital Of Wisconsin Inc
Robert Montgomery is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Montgomery is highly rated in 3 conditions, according to our data. His top areas of expertise are Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, and Immune Thrombocytopenic Purpura (ITP).
Clinical Cancer Center-Froedtert Hospital
Mary Eapen is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Eapen is highly rated in 12 conditions, according to our data. Her top areas of expertise are Graft Versus Host Disease (GvHD), Anemia, Aplastic Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Milwaukee Campus-Children's Wisconsin
Veronica Flood is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Flood is highly rated in 3 conditions, according to our data. Her top areas of expertise are Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, and Hemophilic Arthropathy.
Frequently Asked Questions about Kathryn Asmus, NP
How do I make an appointment with Kathryn Asmus, NP?
You can book an appointment with Kathryn Asmus, NP by calling their office at 262-696-5690. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Kathryn Asmus, NP a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Kathryn Asmus, NP is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Kathryn Asmus, NP specialize in?
While Kathryn Asmus, NP is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Small Lymphocytic Lymphoma (SLL), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Kathryn Asmus, NP accept my insurance?
Kathryn Asmus, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 262-696-5690 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Small Lymphocytic Lymphoma (SLL)Ms. Asmus isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Smoldering Multiple MyelomaMs. Asmus isExperienced. Learn about Smoldering Multiple Myeloma.